Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer.

Objectives: To identify a 50.8-kDa biomarker to perform a preliminary clinical evaluation of its utility as an aid in the early detection of prostate cancer.

Methods: The 50.